Effect of Cyclosporin A on Cardiac Hypertrophy Induced by Catecholamine in Rat

符民桂,王晓红,姜志胜,李淑莲,庞永政,刘乃硅,唐朝枢
DOI: https://doi.org/10.3760/j:issn:0253-3758.2001.01.013
2001-01-01
Abstract:Objectives To determine the effect of cyclosporin A on catecholamine-induced cardiac hypertrophy in rats. Methods The rats were divided into 3 groups: 1) Isoporoterenol-treated group: The rats were injected with isoporoterenol (5 mg*kg-1*d-1); 2) CsA-treated group: Except injection of isoporoterenol, the rats were treated by CsA (20 mg*kg-1*d-1) ; 3) Control group: without any treatment. The heart size, heart/body weight ratio, CaN, MAPK and PKC activity in heart tissues were measured. The effect of CsA to 3H-Leucine incorporation of cultured neonatal rat cardiac myocytes stimulated by norepinephrine was investegated. Results In the isoporoterenol-treated group, the heart size of each rat was increased, the myofibrillar disarray and myofibrilize was evident. The heart size of the rat treated with CsA was not inceased, and CsA treatment prevented the increase in heart/body weight ratio characteristic of the isoporoterenol-treated group. The calcineurin activity in hearts from isoporoterenol-treated group was increased (P<0.05) compared with that of the control group. CsA treatment can reduce the CaN activity in hearts. There was no significant differences in MAPK activity between the three groups, but the PKC activity in hearts from the isoporoterenol-treated group was dramaticly increased (P<0.001), which is reduced by 50% in CsA-treated rat's hearts. CsA can markedly prevent the increase in 3H-Leucine incorporation of cultrued neonatal rat cardiac myocytes promoted by norepinephrine. Conclusion Calcineurin dependent signal pathway may play a role in catecholamine-induced cardiac hypertrophy. CsA can prevent the cardiac hypertrophy by blocking calcineurin- and PKC-mediated signal transduction.
What problem does this paper attempt to address?